Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris
Advanced Healthcare Materials · 2026-08 · 15 (29)
DOI: 10.1002/adhm.71395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.06.2026. Verfasst von Courtney R Johnson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Acne Vulgaris, Nitric Oxide, Nitric Oxide Donors. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIH HHS, National Science Foundation.
Abstract (Originalsprache)
The topical treatment of acne vulgaris by a single therapeutic is difficult given the multifaceted causes of the disease. Treatment with photo‐responsive nitric oxide (NO) donors and light represents an attractive alternative to conventional therapeutics due to the potential for multimodal therapeutic action against downstream acne processes. Herein, a topical hyaluronic acid (HA) formulation was developed to facilitate localized NO delivery from mesoporous silica nanoparticle (MSN) NO donors upon blue light exposure, while simultaneously providing anti‐inflammatory activity. The NO release was tunable (0.09–0.51 µmol NO mg −1 ) depending on wavelength, with shorter wavelengths and greater irradiances providing more efficient photolytic liberation. Antibacterial activity and cytocompatibility were directly modulated by photolytic NO release and payload, where NO was determined to be the primary antibacterial agent and large, initial NO bursts led to preservation of cell viability. Incorporation of the MSN‐based NO donors into an HA formulation afforded additional metabolic and immunomodulatory behavior in vitro, demonstrating potential to decrease sebum production and inflammation in acne vulgaris. Blue light‐mediated NO release from the HA formulation presents a multifunctional therapeutic platform that addresses key contributing downstream factors of acne.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, Florida, USA.
- Eshelman School of Pharmacy, University of North Carolina At Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Courtney R Johnson, Shannon M Wallet, Mark H Schoenfisch
Förderung
- NIDCR NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Johnson, C. R., Picciotti, S. L., Ramrattan, T. D., Nogler, M. E., Bucci, M. P., Reinhard, S. J., Schaefer, C. J., Wallet, S. M., & Schoenfisch, M. H. (2026). Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris. Advanced Healthcare Materials, 15(29). https://doi.org/10.1002/adhm.71395
Vancouver
Johnson CR, Picciotti SL, Ramrattan TD, Nogler ME, Bucci MP, Reinhard SJ, et al. Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris. Advanced Healthcare Materials. 2026;15(29). doi:10.1002/adhm.71395
BibTeX
@article{Johnson2026,
author = {Johnson, Courtney R and Picciotti, Samantha L and Ramrattan, Tsian D and Nogler, Mikaylin E and Bucci, Madelyn P and Reinhard, Simon J and Schaefer, Casimir J and Wallet, Shannon M and Schoenfisch, Mark H},
title = {Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {29},
doi = {10.1002/adhm.71395}
}
EUVIMED